Learn about our new migraine and headache research fund established in honor of Scientific Breakthrough Award recipient Peter Goadsby, MD, PhD
Migraine impacts over 37 million people in the United States. Over the past three decades, Dr. Goadsby, professor of neurology at the David Geffen School of Medicine at UCLA, piloted seminal research that led to the discovery of the role of the calcitonin gene-related peptide (CGRP) in migraine and identified it as a target for drug development. This research led to clinical trials that resulted in the development of biologics and drugs for the preventive and acute treatment of migraine. These medicines changed the lives of countless people living with migraine across the world.
Earlier this year, the American Brain Foundation awarded Dr. Goadsby the Scientific Breakthrough Award in recognition of this incredible contribution to migraine research. His findings prove that the more research we do, the more answers we’ll find and the more people we’ll help. That’s one big reason why we are establishing the Goadsby Headache Research Fund to support:
- Innovative research projects. The grant supports scientists who will advance our understanding of migraine and develop treatments.
- Research that addresses health disparities in the areas of headache and migraine. This includes evaluation of health services, access to care and treatments, quality of care, implementation of therapies, physician performance, or patient adherence.
Thank you to our sponsors AbbVie and Biohaven Pharmaceuticals for helping advance breakthroughs in headache and migraine research. You can also make a difference by backing research grants for these debilitating disorders impacting the lives of millions by supporting the Goadsby Headache Research Fund.
The American Brain Foundation believes that, one day, we will be able to live life without brain disease—and it all starts with funding research to discover cures. Learn more about the research we fund here.